Mark Yates
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Rheumatology 15
- Rheumatoid Arthritis Research and Therapies 12
- Spondyloarthritis Studies and Treatments 2
-
- COVID-19 Clinical Research Studies 5
- Co-authors
- James Benjamin Galloway (29 shared papers)Katie Bechman (17 shared papers)Sam Norton (23 shared papers)Benjamin D Clarke (5 shared papers)Maryam A. Adas (6 shared papers)Andrew P. Cope (11 shared papers)Mark Russell (7 shared papers)Sanketh Rampes (3 shared papers)
- Journals
- Lara D. Veeken (13 papers)The Journal of Rheumatology (3 papers)Journal of Infection (2 papers)Arthritis & Rheumatology (2 papers)BMJ Open (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Mark Yates
41 papers receiving 1.3k citations
Mark Yates's Hit Papers
Peers
Comparison fields: 5 of 91
- Rheumatology 302
- Infectious Diseases 310
- Neurology 129
- Hematology 97
- Immunology 157
Countries citing papers authored by Mark Yates
This map shows the geographic impact of Mark Yates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Yates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Yates more than expected).
Fields of papers citing papers by Mark Yates
This network shows the impact of papers produced by Mark Yates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Yates. The network helps show where Mark Yates may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Yates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 167 | |
| 2 | 2020 | 125 | |
| 3 | Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study Hit paper breakdown → | 2023 | 121 |
| 4 | 2021 | 103 | |
| 5 | 2021 | 93 | |
| 6 | 2022 | 85 | |
| 7 | 2022 | 80 | |
| 8 | 2019 | 76 | |
| 9 | 1997 | 61 | |
| 10 | 2019 | 42 | |
| 11 | 2021 | 41 | |
| 12 | 2016 | 35 | |
| 13 | 2019 | 29 | |
| 14 | 2022 | 23 | |
| 15 | 2020 | 22 | |
| 16 | 2019 | 20 | |
| 17 | 2021 | 17 | |
| 18 | 2021 | 16 | |
| 19 | 2021 | 15 | |
| 20 | 2020 | 15 |
About Mark Yates
Mark Yates is a scholar working on Rheumatology, Infectious Diseases, Epidemiology, Oncology and Immunology, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (12 papers), COVID-19 Clinical Research Studies (5 papers), Cytokine Signaling Pathways and Interactions (2 papers), Spondyloarthritis Studies and Treatments (2 papers), COVID-19 and healthcare impacts (2 papers), COVID-19 and Mental Health (2 papers), Healthcare professionals’ stress and burnout (1 paper) and Congenital Diaphragmatic Hernia Studies (1 paper). The work is most often cited by research in Rheumatology (302 citations), Infectious Diseases (310 citations), Neurology (129 citations), Hematology (97 citations) and Immunology (157 citations). Mark Yates has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include James Benjamin Galloway, Katie Bechman, Sam Norton, Benjamin D Clarke, Maryam A. Adas, Andrew P. Cope, Mark Russell, Sanketh Rampes, Sumera Qureshi and Richard D. Barker. Their work appears in journals such as Lara D. Veeken, The Journal of Rheumatology, Journal of Infection, Arthritis & Rheumatology and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.